<p>Summary of results for CF subjects with G551D mutations. Six adult G551D CF subjects were tested. Table is arranged by subject and condition, each row shows the results for a single test or means/sums when multiple tests were performed. Subjects had been taking ivacaftor for at least 3 weeks prior to (+) ivacaftor testing. Columns labeled ‘gland numbers’ show the number of glands that secreted to an intradermal injection of MCh, then to the β-adrenergic cocktail at the same site (C-sweat), and the ratio of the two expressed as a percentage. Columns labeled ‘gland volumes/rates’ show the average final M-sweat or C-sweat volumes per gland expressed as nanoliters for a 15 min period (M-sweat) or 30 min period (C-sweat) followed by average r...
Background: Investigation of novel cystic fibrosis transmembrane conductance regulator (CFTR) potent...
<p>S5 was tested only once, (+) ivacaftor. (A) Gland-by-gland correlations of M- and C-sweating usin...
We have simplified the published procedure (5) for measuring sweat rates in individual human sweat g...
<p>(A) Columns (left axis) show C-sweat/M-sweat ratios (mean ± SEM) for each subject, expressed as% ...
<p>(A) Examples of M-sweat. (B) Examples of C-sweat. Calibration = 0.5 mm. (C) Gland-by-gland corre...
To determine if oral dosing with the CFTR-potentiator ivacaftor (VX-770, Kalydeco) improves CFTR-dep...
<p>(A) Larger M-sweat responses (+) ivacaftor were seen (uniquely) in this subject. Scatter plot sho...
To determine if oral dosing with the CFTR-potentiator ivacaftor (VX-770, Kalydeco) improves CFTR-dep...
We optically measured effects of orally available ivacaftor (Kalydeco®) on sweat rates of identified...
We optically measured effects of orally available ivacaftor (Kalydeco®) on sweat rates of identified...
Introduction: Sweat chloride concentration, a biomarker of CFTR function, is an appropriate outcome ...
<p>(<b>A</b>) Mean ± SEM for the final (30 min) volume of C-sweat secretion per gland (50–53 glands ...
<p>(A) M-sweat responses were unchanged by ivacaftor in this subject. Each point is log transformed ...
We optically measured effects of orally available ivacaftor (Kalydeco®) on sweat rates of identified...
<p>Each image shows a small region (∼1.5 mm<sup>2</sup>) of the stimulated field of sweat glands (fu...
Background: Investigation of novel cystic fibrosis transmembrane conductance regulator (CFTR) potent...
<p>S5 was tested only once, (+) ivacaftor. (A) Gland-by-gland correlations of M- and C-sweating usin...
We have simplified the published procedure (5) for measuring sweat rates in individual human sweat g...
<p>(A) Columns (left axis) show C-sweat/M-sweat ratios (mean ± SEM) for each subject, expressed as% ...
<p>(A) Examples of M-sweat. (B) Examples of C-sweat. Calibration = 0.5 mm. (C) Gland-by-gland corre...
To determine if oral dosing with the CFTR-potentiator ivacaftor (VX-770, Kalydeco) improves CFTR-dep...
<p>(A) Larger M-sweat responses (+) ivacaftor were seen (uniquely) in this subject. Scatter plot sho...
To determine if oral dosing with the CFTR-potentiator ivacaftor (VX-770, Kalydeco) improves CFTR-dep...
We optically measured effects of orally available ivacaftor (Kalydeco®) on sweat rates of identified...
We optically measured effects of orally available ivacaftor (Kalydeco®) on sweat rates of identified...
Introduction: Sweat chloride concentration, a biomarker of CFTR function, is an appropriate outcome ...
<p>(<b>A</b>) Mean ± SEM for the final (30 min) volume of C-sweat secretion per gland (50–53 glands ...
<p>(A) M-sweat responses were unchanged by ivacaftor in this subject. Each point is log transformed ...
We optically measured effects of orally available ivacaftor (Kalydeco®) on sweat rates of identified...
<p>Each image shows a small region (∼1.5 mm<sup>2</sup>) of the stimulated field of sweat glands (fu...
Background: Investigation of novel cystic fibrosis transmembrane conductance regulator (CFTR) potent...
<p>S5 was tested only once, (+) ivacaftor. (A) Gland-by-gland correlations of M- and C-sweating usin...
We have simplified the published procedure (5) for measuring sweat rates in individual human sweat g...